- The Consumer Technology Association (CTA) honors Earable® Neuroscience with a CES 2025 Innovation Awards® in Digital Health, marking its third consecutive win in 2023-2025.
- Earable announces the upcoming May 2025 launch of the Focus Flow mobile app, a personalized audio therapy platform based on brain waves to improve focus with potential applications in productivity enhancement and memory training.
- Earable launches Brainwaves Labs to advance applied neuroscience research and invite collaboration with pharmaceutical companies, universities and B2B partners.
LAS VEGAS, January 5, 2025 (GLOBE NEWSWIRE) — Earful neuroscience has been honored by the Consumer Technology Association (CTA) with its third consecutive CES Innovation Awards® for FRENZ Brainband’s groundbreaking personalized audio therapy platform, based on real-time brainwave tracking. This groundbreaking technology is advancing the health technology industry and improving the cognitive functions of people around the world. The CTA is the organization behind the Consumer Electronics Show (CES), the world’s most influential technology event.
FRENZ brain band Through Earful neuroscience is a three-time winner of the CES Innovation Award
AI wearable designed to optimize sleep, focus and cognitive performance.
FRENZ Brainband is the first EEG-based wearable and audio therapy platform to earn CES Innovation Awards® in three different categories:
- Wearable technology (2023): FRENZ Brainband – the world’s first AI-powered sleep wearable with CBT-i therapy solutions.
- Accessibility and obsolescence technology (2024): FRENZ Sleep Science Mobile App, clinically proven efficacy and its impact on the longevity industry.
- Digital Healthcare (2025): FRENZ Focus Flow mobile app, the world’s most accurate consumer wearable to track and improve focus through personalized audio therapy.
“Achieving this CES hat-trick is an important milestone,” the spokesperson said Dr. Tam VuFounder of Earable® Neuroscience. “It demonstrates the evolution of FRENZ into a multifunctional, AI-powered EEG-based platform for improving sleep, focus and cognitive performance for everyday application.”
With 35 patents and patent-pending technologies and multiple Best Paper Awards in the field of wearable and AI-based sensory technology, Dr. Vu also appointed to the jury for the AI category of the CES Innovation Awards 2025. In addition, Earable’s Chief Innovation Officer, Kimi Doanwill participate in a panel discussion on neurotechnology at CES on January 7. During the session “Everyday Neurotech: Brain Computer Interfaces for Everyone”, Ms. Doan will talk about how FRENZ integrates cutting-edge neuroscience into practical, everyday applications to improve mental health and productivity.
Revealing Focus Flow
At CES 2025, Earable introduced the Focus Flow mobile app, an innovation that builds on the clinically validated FRENZ Brainband. Focus Flow delivers personalized neurofeedback using real-time brainwave tracking to train the brain for improved concentration during demanding tasks. The science-backed therapy uses specialized frequency music, binaural beats and contextual audio cues, designed to increase beta and gamma activity in the brain’s frontal lobe.
During the event, select media and early user groups experienced real-time demonstrations, examining their brain waves and neuroplasticity scores while engaging with the focus-enhancing feature.
The demo event was co-organized in collaboration with Target Path. Deena Ghazarian, Managing Partner of TargetPath, commented: “At TargetPath, our vision is to partner with innovators who are redefining consumer technology with meaningful applications. Earable’s Focus Flow feature exemplifies this vision by combining real-time brainwave tracking with user-centered design to deliver a breakthrough cognitive enhancement tool.”
“Focus Flow has been in development for more than two years by our internal laboratory team and industry partners, involving more than 10,000 training sessions and millions of focus-epoch samples,” said Dr. Vu. “With our R&D roadmap, this feature not only delivers a cognitive boost, but also advances our understanding of brain waves as biomarkers for mental health and cognitive performance.”
Global call for B2B partnerships
Earable Neuroscience launched at CES2025 FRENZ Brainwave Labsa platform designed to foster meaningful collaborations with universities, pharmaceutical companies and corporate wellness programs. Partners gain access to advanced APIs, raw data, and the ability to co-develop advanced algorithms tailored to their unique needs.
“FRENZ Brainwaves Labs connects scientific innovation with practical applications,” said Kimi Doan. “By using advanced brainwave monitoring and sleep recording as biomarkers, we want to unlock new possibilities in the field of cognitive health. Research areas currently include the discovery of neurodegenerative diseases, epilepsy monitoring, stroke rehabilitation, pain management and neuroplasticity.”
The FRENZ Brainband for B2B is globally recognized and provides unparalleled, accurate, real-time, research-quality access to biomarkers including brain waves (EEG), heart rate, SpO2, facial muscle activity (EMG) and eye movements (EOG).
FRENZ Brainwaves Labs collaborates with MedM, a world leader in Remote Patient Monitoring (RPM). MedM is known for its sensor-agnostic compatibility and seamless integration with leading healthcare systems, along with its consumer app, which has more than 500,000 users worldwide. Scheduled for launch in the second quarter of 2025, this collaboration reinforces Earable’s commitment to making advanced neuroscience accessible worldwide.
Building on patented core technologies and a growing global footprint, Earable® Neuroscience invites academic institutions, pharmaceutical companies, healthcare innovators and corporate wellness leaders to collaborate. Together we can transform brainwave technology into meaningful solutions for improving sleep, focus and overall cognitive well-being.
The CES Innovation Awards are based on descriptive material submitted to the judges. CTA has not verified the accuracy of any entries or claims and has not tested the item awarded the award.
About Earable® Neuroscience
FRENZ brain band Through Earful neuroscience is a 3x CES Innovation Award-winning AI wearable designed to optimize sleep, focus and cognitive performance. Using real-time brainwave tracking and personalized audio therapy, FRENZ delivers clinically proven, evidence-based solutions to help users fall asleep faster, stay focused and improve mental recovery. Supported by Samsung companies And Founders FundFRENZ has been characterized as one Top tech trend to watch in BBC, Bloomberg, The Wall Street Journal, Daily mail, The times, USA today, Rated.com, Mashable, Yahoo! FinancesAnd Euro news.
Media contact [email protected]
B2B/Research Contact: [email protected] – Chief Innovation Officer
Website: frenzband.com
https://www.globenewswire.com/NewsRoom/AttachmentNg/50d1fbb8-a746-4e00-a215-330dab70a80b
